聚焦超声:神经外科中的增长潜力与未来方向
本文综述聚焦超声(FUS)技术近二十年在神经外科领域的发展,指出FUS已获美国食品药品监督管理局(FDA)批准用于治疗两种神经系统疾病,并探讨其未来在组织消融、血脑屏障开放和基因治疗方面的应用前景。文章还将FUS与深部脑刺激和立体定向放射外科等现有技术进行比较,并总结FUS在神经外科界广泛应用前需克服的技术与基础设施挑战。
要点
- FUS已获FDA批准用于两种神经系统疾病治疗
- 未来重点方向包括组织消融、血脑屏障开放和基因治疗
- FUS广泛应用前需克服技术与基础设施挑战
核心结论
- FUS技术近二十年取得巨大进步,已成为神经外科治疗手段的有益补充,并有望扩展可干预的病变谱。
研究设计与样本
- 本文为综述,检索范围未在摘要中报告。
主要发现
- FUS已获FDA批准用于治疗两种神经系统疾病。
- FUS的未来应用包括组织消融、血脑屏障开放和基因治疗。
- FUS与深部脑刺激和立体定向放射外科等现有技术存在潜在角色比较。
临床怎么用
- 神经外科医生可关注FUS在组织消融、血脑屏障开放和基因治疗方面的未来应用。
- 临床决策时可比较FUS与深部脑刺激、立体定向放射外科等 established 技术的潜在角色。
局限性
- FUS在神经外科界广泛应用前仍需克服技术与基础设施方面的挑战。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Over the past two decades, vast improvements in focused ultrasound (FUS) technology have made the therapy an exciting addition to the neurosurgical armamentarium. In this time period, FUS has gained US Food and Drug Administration (FDA) approval for the treatment of two neurological disorders, and ongoing efforts seek to expand the lesion profile that is amenable to ultrasonic intervention. In the following review, we highlight future applications for FUS therapy and compare its potential role against established technologies, including deep brain stimulation and stereotactic radiosurgery. Particular attention is paid to tissue ablation, blood-brain-barrier opening, and gene therapy. We also address technical and infrastructural challenges involved with FUS use and summarize the hurdles that must be overcome before FUS becomes widely accepted in the neurosurgical community.
引用
- Zhang M, Rodrigues A, Zhou Q, et al. Focused ultrasound: growth potential and future directions in neurosurgery. J Neurooncol. 2021. PMID: 34410576. doi:10.1007/s11060-021-03820-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。